Public data may help identify drugs associated with shortages, but hospital inventory and purchasing data could make early-warning tools more useful.
Feature|Articles|December 30, 2025
Interview with Sa'ed al-Olimat, PharmD: The Case for Pharmacists as Stewards of Ethical Psychadelic Care
Author(s)Sa'ed Al-Olimat, PharmD
Fact checked by: Laura Silvius, Managing Editor
Pharmacists play a vital role in the safe integration of psychedelics into healthcare, addressing ethical concerns and ensuring equitable access to treatments.
Advertisement
Advertisement
As psychedelic therapies moved closer to adoption in 2025, questions of safety, access, and ethical use continue to emerge. Sa'ed al-Olimat, PharmD, co-founder of Psychedelic Pharmacists Association, believes his colleagues in pharmacies across the country are ideally positioned and ideally suited to help set high standards for how these therapies are introduced. In part 2 of his interview with Pharmacy Times, he discussed balancing cultural humility with addressing unmet medical needs.
Related to this article
Parminder K. Judge, PhD, explains why eGFR and electrolytes should be monitored when diuretics are added to reach intensive BP targets in patients with CKD
In an era of rapidly evolving technology, we remain in a people-powered world.
Tucatinib’s new HER2-positive breast cancer maintenance indication extends disease control while requiring close liver monitoring and pharmacist coordination of oral therapy with ongoing antibody treatment.
Impostor syndrome prevalence in oncology pharmacists is a complex topic that is not well described.
This quiz was created in collaboration with PTCE™.
Pharmacy professionals can leverage LinkedIn to build a professional brand, expand meaningful connections, share expertise, and create opportunities for career growth.
An Italian pharmacy student offers an inside look at pharmacy education in Italy, from admission and coursework to oral exams and professional training.
Advertisement
Advertisement